Now Live: Healthark’s Latest GCC Whitepaper

Read more

A book by Healthark

Crafted in collaboration with senior leaders from leading GCCs. It brings together the leadership decisions and lessons that have defined India’s LSHC GCC journey over the past two decades.

Dr. Purav Gandhi

Healthark

Sudeep Krishna

Healthark

John Dawber

Novo Nordisk

Sanjay Patel

Chandani Palshetkar

Opella

Vignesh Krishnakumar

Roche

Nilay Shastri

Roche

India’s Rise as the Global Hub for LSHC GCCs

Over two decades, India has grown from an offshore support base into a global headquarters for healthcare innovation, technology, and enterprise operations. Nearly half of the world’s top life sciences and healthcare (LSHC) companies now run a Global Capability Center (GCC) in India. “Unlocking India as the Strategic Hub for LSHC GCCs” brings this story together in one place. It traces how these centers evolved, what makes the current model distinct, and why they matter to global strategy.

Where Global LSHC Innovation is Taking Shape

Drawing on leadership insights from Novo Nordisk, Roche, and Opella, the book shows how India’s LSHC GCCs advance AI-led drug discovery and real-world evidence. It also examines the ecosystem behind this growth, from state GCC policies and specialized clusters to emerging cities and deep talent pools. Explore how specialized hubs across India are taking on higher-value work for global life sciences and healthcare organizations.

India’s GCCs Have Stepped Into the Lead Role in LSHC

India has become central to how global life sciences and healthcare organizations build, innovate, and lead. This book maps the strengths driving that role and what they mean for organizations deciding where and how to build their next capabilities.
REQUEST YOUR COPY

Frequently Asked Questions

What does the book “Unlocking India as the Strategic Hub for LSHC GCCs” cover?

The book offers a complete view of India’s LSHC GCC ecosystem, from how it evolved to the cities, companies, and technologies shaping it today. It also examines the challenges ahead and what the next phase means for global life sciences and healthcare organizations.

India offers deep talent pools, a mature technology ecosystem, and policy support from several states. Organizations use them to run global functions such as clinical development, pharmacovigilance, and regulatory from India, and to build AI and digital platforms.

AI is redefining what India’s LSHC GCCs can own, from AI-led drug discovery and digital clinical trials to real-world evidence. The real opportunity lies in rethinking how work is done, not adding AI to existing processes, with quality, governance, and human judgment built in.

The book is crafted by Healthark founders Dr. Purav Gandhi, Founder & CEO, and Sudeep Krishna, Co-Founder & President. Senior leaders from leading GCCs co-authored it, including John Dawber (Novo Nordisk), Chandani Palshetkar (Opella), Nilay Shastri (Roche), Krishnakumar Vignesh (Roche), and Sanjay Patel.

This book is for senior leaders, strategy teams, and consultants in life sciences and healthcare, especially those planning or scaling a GCC in India. Whether you are exploring India for the first time or expanding an established center, this is the right read for you.

Simply click on “Request Your Copy” and fill in your details. You will receive an email confirmation, following which someone from the Healthark team will connect with you.